Press Policy

The following policies have been established for journalists attending or covering the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL) biennial meeting, as well as for presenters, exhibitors, and/or public relations professionals wishing to distribute materials related to the research being presented at iwCLL.

Individuals, companies, organizations, or institutions found in violation of these policies will have their access to the iwCLL meeting revoked.

For information or questions about the following media policy, please contact: iwCLL at 888-476-9129 or


  1. Embargo Information
  2. Press Release Information
  3. Press Policies and Registration
  4. Exhibitor and Public Relations Materials/Events
  5. Press Resources


Companies and institutions are allowed to disseminate press releases in association with the 19th International Workshop on Chronic Lymphocytic Leukemia (iwCLL); however, all materials are embargoed according to the following:

Abstract Title Embargo: Titles of abstracts submitted to iwCLL are embargoed until the titles are made public on the iwCLL website on August 27, 2021 at 5:00 pm PDT.

Abstract Content Embargo: The full listing of abstracts and abstract content will be made available on the iwCLL mobile app. Therefore, the Abstract Content Embargo will officially be lifted as of September 13, 2021 at 14:00 CEST. Abstract content will only be released to registered attendees of the program.

Presentation Embargoes:

Poster-Only Presentations: Any additional data in a poster (beyond what is included in the abstract) is embargoed until Monday, September 13, 2021, 14:00 CEST This embargo applies to poster-only presentations.

Oral Abstract Presentations: Any updated and/or new data (beyond what is included in the abstract) in an oral presentation is embargoed until the start of the session in which the presentation is being shared.

If the oral presenter is creating both a poster and an oral presentation containing updated and/or new data, both the poster and oral presentation will share this same Oral Abstract Presentation embargo.


Any planned press releases or media alerts related to iwCLL must comply with the following guidelines:

Press Release Format Guidelines:

  • Abstract number included in the top left corner of the release (above the headline)
  • iwCLL mentioned either in the headline or subhead
  • iwCLL referenced in the first paragraph (using iwCLL after the first mention) as follows:

19th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting

Pre-Meeting Press Releases: These releases (such as a Curtain-Raiser Release) may be issued with only logistical information (for instance, the title, poster number, and presentation date and time) about an abstract/poster/oral presentation according to the Abstract Title Embargo date (see above).

Data Press Releases:

Abstract Content-Only Releases may be issued with information from the accepted abstract at the official start of the meeting (September 13, 2021 at 14:00 CEST), when the full listing of abstracts and abstract content is made available on the iwCLL mobile app.

Poster-Only Presentation Releases containing updated and/or new information (including data beyond what is included in the accepted abstract) that will be presented in a poster may be issued according to the Poster-Only Presentations Embargo (see embargo timing above).

Oral Abstract Presentation Releases containing updated and/or new information (beyond what is included in the accepted abstract) that will be presented in an oral presentation may be issued according to the Oral Abstract Presentation Embargo (see above).

NOTE:  Journalists deemed in violation of any iwCLL Media Policy will have their meeting press privileges revoked.


In general, registered media may:

  • Take screen shots for publication
  • Record audio of the sessions and poster presentations for their personal use (not for publication)
  • Live-streaming of any meeting materials, including all presentations and posters, is strictly prohibited. Video recording of sessions and poster presentations is also strictly prohibited, except for press briefings.
  • Social media: Sharing unembargoed screen shots of presenter slides on social media during the meeting is permitted, but the post must give attribution to the study author/presenter.


iwCLL will provide complimentary meeting registration to professional journalists representing media organizations for the express purpose of gathering news and information to produce media coverage of the meeting.

To gain access to iwCLL, journalists and medical/science writers must register for the program providing all requested information, as well as abide by the media policies outlined within this document.

Please note: Under no circumstances will contact information of registered press be made available.

Registration Form and Credentials:

  • All individuals registering as press must complete and return the press registration form (available below), along with a copy of their press credentials.
  • Freelance journalists must present a letter of assignment on letterhead from a recognized news organization or publication.
  • iwCLL will consider bloggers for press registration on a case-by-case basis.

Public information officers and communications professionals from educational institutions, government agencies, and nonprofit cancer research organizations are each allowed up to two complimentary registrations.

Journalists working for medical and scientific publishing companies must have proof of an editorial assignment in order to register, and the publication must have:

  • a regular editorial news section;
  • multiple sponsors (no single-sponsor publications); and
  • complete editorial freedom from their sponsors.

Registration Instructions:

To register, please click HERE  and complete your registration by selecting the PRESS category


No exceptions will be made to the following policies:

  • Materials may not indicate iwCLL endorsement or use the iwCLL logo.


The iwCLL 2021 Program including the full abstracts, will be provided on the iwCLL mobile app.